Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany

European Journal of Epidemiology

Volumn 27, Issue 7, 2012, Pages 519-524

  Claessen, Heiner ^a   Genz, Jutta ^a   Bertram, Bernd ^b   Trautner, Christoph ^c   Giani, Guido ^a   Zöllner, Iris ^d   Icks, Andrea ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Ophthalmologic Office   (Germany)

^c UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d Baden Württemberg State Health Office ^*  (Germany)

Author keywords

Blindness; Cause specific blindness incidences; Germany; Incidences

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLINDNESS; BLOOD VESSEL OCCLUSION; CATARACT; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE REGISTRY; FEMALE; GERMANY; GLAUCOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE ATROPHY; OUTCOME ASSESSMENT; POPULATION RESEARCH; RETINA MACULA DEGENERATION; SEX DIFFERENCE; TREND STUDY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLINDNESS; CHILD; CHILD, PRESCHOOL; DIABETIC RETINOPATHY; FEMALE; GERMANY; GLAUCOMA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MACULAR DEGENERATION; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84866035979     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9705-7     Document Type: Article

References (30)

1. Wu L, Sun X, Zhou X, Weng C. Causes and 3-year incidence of blindness in Jing-An District, Shanghai, China, 2001-2009. BMC Ophthalmol. 2011;11:10.
2. Avisar R, Friling R, Snir M, Avisar I, Weinberger D. Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Isr Med Assoc J. 2006;8:880-1.
3. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-85.
4. Krumpaszky HG, Klaus V. Zeittrends bei Erblindungsursache [Time trends of causes of blindness]. Klin Monatsbl Augenheilk. 1997;210:9-16 (German).
5. Bertram B, Hammers H. Die Prävalenz der Erblindungen wegen diabetischer Retinopathie steigt weiter [The prevalence of loss of eyesight due to diabetic retinopathy continues to rise]. Z Prakt Augenheilkd. 1997;18:181-4 (German).
6. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health. 2006;6:58.
7. Statistisches Bundesamt. Statistik der Schwerbehinderten Menschen [Statistic of seriously disabled people]. Wiesbaden: Statistisches Bundesamt; 2009 (German). http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/ Internet/DE/Content/Publikationen/Fachveroeffentlichungen/Sozialleistungen/ SozialSchwerbehinderte2007pdf,property=file.pdf. Accessed 20 Dec 2011.
8. Statistisches Bundesamt. Bevölkerung nach dem Gebietsstand [Population according to the area]. Berlin: Statistisches Bundesamt; 2011 (German). http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/ Content/Statistiken/Zeitreihen/LangeReihen/Bevoelkerung/Content75/lrbev03a, templateId=renderPrint.psml. Accessed 20 Dec 2011.
9. Ministry of Social Affairs of Baden-Württemberg, personal communication, 2010.
10. Statistisches Landesamt Baden-Württemberg. Statistische Berichte Baden-Württemberg: Bevölkerung und Erwerbstätigkeit. Artikel-Nr. 3121 11002 [Statistical reports of Baden-Württemberg: population and employment. Article-No. 312 11002]. Stuttgart: Statistisches Landesamt Baden-Württemberg; 2011 (German). http://www.statistik-bw.de/Veroeffentl/ Statistische-Berichte/3121-11002.pdf. Accessed 20 Dec 2011.
11. Finger RP, Fimmers R, Holz FG, Scholl HP. Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol. 2011;95:1061-7.
12. Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye. 2010;24:1692-9.
13. Trautner C, Haastert B, Giani G, Berger M. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia. 2001;44:147-50.
14. Genz J, Scheer M, Trautner C, Zöllner I, Giani G, Icks A. Reduced incidence of blindness in relation to diabetes mellitus in southern Germany? Diabet Med. 2010;27:1138-43.
15. Trautner C, Haastert B, Richter B, Berger M, Giani G. Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci. 2003;44:1031-4.
16. Trautner C, Icks A, Haastert B, Plum F, Berger M. Incidence of blindness in relation to diabetes: a population-based study. Diabetes Care. 1997;20:1147-53.
17. Icks A, Trautner C, Haastert B, Berger M, Giani G. Blindness due to diabetes: population-based age- and sex-specific incidence rates. Diabet Med. 1997;14:571-5.
18. Finger RP, Fimmers R, Holz FG, Scholl HPN. Incidence of blindness and severe visual impairment in Germany-projections for 2030. Invest Ophthalmol Vis Sci. 2011;52:4381-9.
19. Work Group Epidemiological Methods. Good practice analysis of secondary data: revision after detailed working-over. Gesundheitswesen. 2008;70:54-60 (German).
20. Wolfram C, Pfeiffer N. Blindness and low vision in Germany 1993-2009. Ophthalmic Epidemiol. 2012;19:3-7.
21. Pauleikhoff D, Kirchhof B, Bertram B, et al. New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with anti-VEGF therapy. Ophthalmologe. 2011;108:85-90 (article in German).
22. Current position of the Retinological Society, the German Ophthalmology Society and the Professional Union of Ophthalmologists in Germany. New aspects in the management of exudative age-related macular degeneration. Klin Monbl Augenheilkd. 2009;226:388-95 (article in German).
23. Ip MS, Scott IU, Brown GC, et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2008;115:1837-46.
24. Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209-13.e2.
25. Lin SC, Singh K, Jampel HD, et al. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology. 2007;114:1937-49.
26. Erratum in Ophthalmology. 2008;115:472.
27. Hoffmeister L, Román R, Comas M, Cots F, Bernal-Delgado E, Castells X. Time-trend and variations in the proportion of secondeye cataract surgery. BMC Health Serv Res. 2007;7:53.
28. Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol. 2012;153(214-21):e1.
29. Gunnlaugsdottir E, Arnarsson A, Jonasson F. Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study. Acta Ophthalmol Scand. 2010;88:358-66.
30. Buch H. Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2005;83:400-1.